Report Detail
Global Microbiome Therapies Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4511523 |
- 16 February, 2023 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Medical Devices & Consumables
Microbiome is a collective genome of microorganisms that reside inside and outside of the body, ranging from pathogenic to beneficial.
According to our (Global Info Research) latest study, the global Microbiome Therapies market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Microbiome Therapies market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Microbiome Therapies market size and forecasts, in consumption value ($ Million), 2018-2029
Global Microbiome Therapies market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Microbiome Therapies market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Microbiome Therapies market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microbiome Therapies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microbiome Therapies market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include uBiome, Evolve BioSystems, Indigo Agriculture, Pivot Bio and Concentric Ag, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Microbiome Therapies market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bacteria
Fungi
Virus
Others
Market segment by Application
Testing Centres
Research Labs
Horticulture
Others
Market segment by players, this report covers
uBiome
Evolve BioSystems
Indigo Agriculture
Pivot Bio
Concentric Ag
Epibiome
CosmosID
Human Longevity
Ajinomoto Cambrooke
AnimalBiome
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Microbiome Therapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Microbiome Therapies, with revenue, gross margin and global market share of Microbiome Therapies from 2018 to 2023.
Chapter 3, the Microbiome Therapies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Microbiome Therapies market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Microbiome Therapies.
Chapter 13, to describe Microbiome Therapies research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Microbiome Therapies
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Microbiome Therapies by Type
- 1.3.1 Overview: Global Microbiome Therapies Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Microbiome Therapies Consumption Value Market Share by Type in 2022
- 1.3.3 Bacteria
- 1.3.4 Fungi
- 1.3.5 Virus
- 1.3.6 Others
- 1.4 Global Microbiome Therapies Market by Application
- 1.4.1 Overview: Global Microbiome Therapies Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Testing Centres
- 1.4.3 Research Labs
- 1.4.4 Horticulture
- 1.4.5 Others
- 1.5 Global Microbiome Therapies Market Size & Forecast
- 1.6 Global Microbiome Therapies Market Size and Forecast by Region
- 1.6.1 Global Microbiome Therapies Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Microbiome Therapies Market Size by Region, (2018-2029)
- 1.6.3 North America Microbiome Therapies Market Size and Prospect (2018-2029)
- 1.6.4 Europe Microbiome Therapies Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Microbiome Therapies Market Size and Prospect (2018-2029)
- 1.6.6 South America Microbiome Therapies Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Microbiome Therapies Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 uBiome
- 2.1.1 uBiome Details
- 2.1.2 uBiome Major Business
- 2.1.3 uBiome Microbiome Therapies Product and Solutions
- 2.1.4 uBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 uBiome Recent Developments and Future Plans
- 2.2 Evolve BioSystems
- 2.2.1 Evolve BioSystems Details
- 2.2.2 Evolve BioSystems Major Business
- 2.2.3 Evolve BioSystems Microbiome Therapies Product and Solutions
- 2.2.4 Evolve BioSystems Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Evolve BioSystems Recent Developments and Future Plans
- 2.3 Indigo Agriculture
- 2.3.1 Indigo Agriculture Details
- 2.3.2 Indigo Agriculture Major Business
- 2.3.3 Indigo Agriculture Microbiome Therapies Product and Solutions
- 2.3.4 Indigo Agriculture Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Indigo Agriculture Recent Developments and Future Plans
- 2.4 Pivot Bio
- 2.4.1 Pivot Bio Details
- 2.4.2 Pivot Bio Major Business
- 2.4.3 Pivot Bio Microbiome Therapies Product and Solutions
- 2.4.4 Pivot Bio Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Pivot Bio Recent Developments and Future Plans
- 2.5 Concentric Ag
- 2.5.1 Concentric Ag Details
- 2.5.2 Concentric Ag Major Business
- 2.5.3 Concentric Ag Microbiome Therapies Product and Solutions
- 2.5.4 Concentric Ag Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Concentric Ag Recent Developments and Future Plans
- 2.6 Epibiome
- 2.6.1 Epibiome Details
- 2.6.2 Epibiome Major Business
- 2.6.3 Epibiome Microbiome Therapies Product and Solutions
- 2.6.4 Epibiome Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Epibiome Recent Developments and Future Plans
- 2.7 CosmosID
- 2.7.1 CosmosID Details
- 2.7.2 CosmosID Major Business
- 2.7.3 CosmosID Microbiome Therapies Product and Solutions
- 2.7.4 CosmosID Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 CosmosID Recent Developments and Future Plans
- 2.8 Human Longevity
- 2.8.1 Human Longevity Details
- 2.8.2 Human Longevity Major Business
- 2.8.3 Human Longevity Microbiome Therapies Product and Solutions
- 2.8.4 Human Longevity Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Human Longevity Recent Developments and Future Plans
- 2.9 Ajinomoto Cambrooke
- 2.9.1 Ajinomoto Cambrooke Details
- 2.9.2 Ajinomoto Cambrooke Major Business
- 2.9.3 Ajinomoto Cambrooke Microbiome Therapies Product and Solutions
- 2.9.4 Ajinomoto Cambrooke Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Ajinomoto Cambrooke Recent Developments and Future Plans
- 2.10 AnimalBiome
- 2.10.1 AnimalBiome Details
- 2.10.2 AnimalBiome Major Business
- 2.10.3 AnimalBiome Microbiome Therapies Product and Solutions
- 2.10.4 AnimalBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 AnimalBiome Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Microbiome Therapies Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Microbiome Therapies by Company Revenue
- 3.2.2 Top 3 Microbiome Therapies Players Market Share in 2022
- 3.2.3 Top 6 Microbiome Therapies Players Market Share in 2022
- 3.3 Microbiome Therapies Market: Overall Company Footprint Analysis
- 3.3.1 Microbiome Therapies Market: Region Footprint
- 3.3.2 Microbiome Therapies Market: Company Product Type Footprint
- 3.3.3 Microbiome Therapies Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Microbiome Therapies Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Microbiome Therapies Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Microbiome Therapies Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Microbiome Therapies Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Microbiome Therapies Consumption Value by Type (2018-2029)
- 6.2 North America Microbiome Therapies Consumption Value by Application (2018-2029)
- 6.3 North America Microbiome Therapies Market Size by Country
- 6.3.1 North America Microbiome Therapies Consumption Value by Country (2018-2029)
- 6.3.2 United States Microbiome Therapies Market Size and Forecast (2018-2029)
- 6.3.3 Canada Microbiome Therapies Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Microbiome Therapies Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Microbiome Therapies Consumption Value by Type (2018-2029)
- 7.2 Europe Microbiome Therapies Consumption Value by Application (2018-2029)
- 7.3 Europe Microbiome Therapies Market Size by Country
- 7.3.1 Europe Microbiome Therapies Consumption Value by Country (2018-2029)
- 7.3.2 Germany Microbiome Therapies Market Size and Forecast (2018-2029)
- 7.3.3 France Microbiome Therapies Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Microbiome Therapies Market Size and Forecast (2018-2029)
- 7.3.5 Russia Microbiome Therapies Market Size and Forecast (2018-2029)
- 7.3.6 Italy Microbiome Therapies Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Microbiome Therapies Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Microbiome Therapies Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Microbiome Therapies Market Size by Region
- 8.3.1 Asia-Pacific Microbiome Therapies Consumption Value by Region (2018-2029)
- 8.3.2 China Microbiome Therapies Market Size and Forecast (2018-2029)
- 8.3.3 Japan Microbiome Therapies Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Microbiome Therapies Market Size and Forecast (2018-2029)
- 8.3.5 India Microbiome Therapies Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Microbiome Therapies Market Size and Forecast (2018-2029)
- 8.3.7 Australia Microbiome Therapies Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Microbiome Therapies Consumption Value by Type (2018-2029)
- 9.2 South America Microbiome Therapies Consumption Value by Application (2018-2029)
- 9.3 South America Microbiome Therapies Market Size by Country
- 9.3.1 South America Microbiome Therapies Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Microbiome Therapies Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Microbiome Therapies Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Microbiome Therapies Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Microbiome Therapies Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Microbiome Therapies Market Size by Country
- 10.3.1 Middle East & Africa Microbiome Therapies Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Microbiome Therapies Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Microbiome Therapies Market Size and Forecast (2018-2029)
- 10.3.4 UAE Microbiome Therapies Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Microbiome Therapies Market Drivers
- 11.2 Microbiome Therapies Market Restraints
- 11.3 Microbiome Therapies Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Microbiome Therapies Industry Chain
- 12.2 Microbiome Therapies Upstream Analysis
- 12.3 Microbiome Therapies Midstream Analysis
- 12.4 Microbiome Therapies Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Microbiome Therapies. Industry analysis & Market Report on Microbiome Therapies is a syndicated market report, published as Global Microbiome Therapies Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Microbiome Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
